Biotechnology Market Size, Share, Growth Analysis, By Product(Instrument & Reagent, Clinical Diagnostics, Proteomics & Genomics, Drug Discovery, Cell Analysis, Others), Technology(Nanobiotechnology, PCR Technology, Bioinformatics, Others), Type, Application, and Region - Industry Forecast 2024-2031


Report ID: SQMIG35H2249 | Region: Global | Published Date: July, 2024
Pages: 260 |Tables: 128 |Figures: 77

Biotechnology Market Insights

Biotechnology Market size was valued at USD 1.21 Trillion in 2022 and is poised to grow from USD 1.38 Trillion in 2023 to USD 3.90 Trillion by 2031, growing at a CAGR of 13.9% during the forecast period (2024-2031).

Biotech industry is one of the globalized sectors. Investment in business is characterized by greatly diversified economic growth among countries. The expansion of problems such as hepatitis B disease as well as other issues is expected to drive the expansion in this field. The demand for subsistence and agricultural products such as wheat, rice, sugarcane and beans are expected to increase mainly because the population in US, China, and India is on the rise, and this will boost the importance of these products. Furthermore, scientists are involved in wide research and development activities to address problems such as water shortage, low productivity, insect attacks, and limited farmland. Their focus is on the improvement of smart systems and helping the industry by partnering with other organizations. Large scale associations, including government subsidized organizations and other independent communities acting against biotechnology funding, on the other hand, boost financing to R&D and new product development programs. 

The ongoing high incidents of either chronic diseases like diabetes or cancers across the globe are expected to increase the demand for biotechnology products in the coming years. Also, the prevalence of type 2 diabetes among many individuals is seeing a growing trend around the world and thus, the market is likely to experience higher margins. The wide range of uses as well as the currently existing demand for highly effective drugs and treatment options, companies that devote themselves to this branch would presumably benefit more. 

US Biotechnology Market is poised to grow at a sustainable CAGR for the next forecast year.

Market Snapshot - 2024-2031

Global Market Size

USD 1.21 Trillion

Largest Segment

DNA sequencing

Fastest Growth

Nanobiotechnology

Growth Rate

13.9% CAGR

Global Biotechnology Market ($ Bn)
Country Share for North America Region (%)

To get more reports on the above market click here to Buy The Report

Biotechnology Market Segmental Analysis

The global biotechnology market is segmented by type, product, technology, application, and region. Based on type the market is segmented into blue biotechnology, green biotechnology, red biotechnology, white biotechnology, and others. Based on product the market is segmented into instrument & reagent (clinical diagnostics, proteomics and genomics, drug discovery & development, cell analysis, others), and software & services. Based on technology, the market can be segmented into nanobiotechnology, PCR technology, bioinformatics, tissue engineering, DNA sequencing, fermentation technology, and others. Based on application, the market is segmented into health, agriculture, food and beverages, industrial processing, and others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.  

Analysis by Product 

Instruments and reagents are projected to account for a major chunk of the global biotechnology market share over the coming years. High investments in biotechnology R&D will require researchers to opt for different types of instruments and reagents, which helps this segment bring in major revenue. Growing emphasis on advancements in research will also boost the demand for novel instruments and reagents thereby cementing the dominance of this segment through 2031.  

On the other hand, the demand for software and services is slated to increase at a robust pace in the long run. Growing emphasis on technology utilization in the biotechnology market is slated to help this segment boost market growth at a notable CAGR in the future. Increasing need for biotechnology services and software by different healthcare establishments will also help this segment boost its market share.  

Analysis by Type 

Red biotechnology holds sway in terms of revenue generation for the global biotechnology market. Red biotechnology refers to any kind of research and development of biotechnology that is aimed at the healthcare and life sciences industry. High investments in medical R&D and rising prevalence of chronic diseases are majorly contributing to the dominance of this segment.  

Meanwhile, the demand for green biotechnology is projected to surge at an impressive pace going forward.  The adoption of precision and smart farming practices is estimated to bolster the demand for green biotechnology. Growing investments in improving agricultural yield and improve livestock health will also favor biotechnology demand outlook. 

Global Biotechnology Market By Application

To get detailed analysis on other segments, Request For Free Sample Report

Biotechnology Market Regional Insights

Robust investments in medical R&D are contributing to the high market share of North America. Presence of a developed healthcare infrastructure, quick adoption of novel technologies, and presence of key biotechnology companies are also helping this region’s dominance. The United States is slated to be the most opportune market for biotechnology companies in this region followed by Canada. Rapidly aging population and rising prevalence of cancer and diabetes are also expected to help boost biotechnology demand outlook in this region.  

Meanwhile, the demand for biotechnology is slated to surge at an impressive pace in the Asia Pacific region over the coming years. Growing investments in healthcare infrastructure development and supportive government initiatives to promote biotechnology R&D are also making this region a highly opportune one for biotechnology market players. Japan, China, and India are estimated to be the top markets in this region going forward. Regulatory compliance is projected to be a major concern in this region as regulations vary vastly across the region. 

Global Biotechnology Market By Region
  • Largest
  • Fastest

To know more about the market opportunities by region and country, click here to
Buy The Complete Report

Biotechnology Market Dynamics

Biotechnology Market Driver

High Incidence of Chronic Diseases 

  • Incidence of chronic diseases such as cancer and diabetes has increased on a global level. Subsequently the demand for treatment of these diseases is also increasing at a rapid pace and fueling the global biotechnology market growth all over the world.  

Rising Demand for Personalized Medicine 

  • Personalized medicine utilizes biotechnology to its fullest from identification of genome to development of personalized medicines. Which is why as demand for personalized medicine increases it will also greatly benefit biotechnology market development in the future.  

Restraints 

Intellectual Property Claim Disputes 

  • Biotechnology is all about innovation and if any company beats another to innovation and files a patent, it could increase the time to market for other company’s products as they cannot utilize a similar patented approach. These overlaps and disputes regarding intellectual property and patents inhibit market growth potential.  

Ethical Concerns and Challenges 

  • Some aspects of biotechnology such as genetic engineering, stem cell research, and human cloning are deemed ethically incorrect and some even state it is against human morals. Hence, resistance to some ethically complex approaches in biotechnology also slow down biotechnology demand outlook.

Request Free Customization of this report to help us to meet your business objectives.

Biotechnology Market Competitive Landscape

Biotechnology companies should solely focus on perfecting their R&D divisions first to maximize their business scope in the future. Collaborations, mergers, and capital raises are projected to be preferred strategies for incoming biotechnology companies looking to penetrate the market. Use of advanced technologies such as artificial intelligence and machine learning will also present new opportunities for biotechnology market players going forward.

Biotechnology Market Top Player's Company Profiles

  • AstraZeneca (UK) 
  • Gilead Sciences, Inc. (US) 
  • Biogen Inc. (US) 
  • Merck (Germany) 
  • Illumina, Inc. (US) 
  • Novo Nordisk A/S (Denmark) 
  • Thermo Fisher Scientific Inc. (US) 
  • Agilent Technologies, Inc. (US) 
  • Lonza Group AG (Switzerland) 
  • Pfizer Inc. (US) 
  • Bristol-Myers Squibb (US) 
  • Amgen Inc. (US) 
  • AbbVie Inc. (US) 
  • Regeneron Pharmaceuticals, Inc. (US) 
  • Vertex Pharmaceuticals Incorporated (US) 
  • Roche Holding AG (Switzerland) 
  • Johnson & Johnson Services, Inc. (US) 
  • Moderna, Inc. (US) 
  • Bio-Rad Laboratories, Inc. (US) 
  • Qiagen N.V. (Netherlands)

Biotechnology Market Recent Developments

  • Mirador Therapeutics, a new biotechnology company focusing on the treatment of immune-related diseases launched with USD 400 million in funding in March 2024. Mirador360 is the company’s novel offering that helps it to develop precision medicines.
  • In October 2023, the subsidiary of Gilead, Kite and Epicrispr Biotechnologies, announced a research collaboration and licensing agreement to apply the gene regulation platform of the latter in the production of advanced cancer cell therapies. 

  • In September 2023, Merck KGaA formed collaborations with BenevolentAI and Exscientia—two companies that use AI for drug discovery in oncology, neurology, and immunology—which may result in the emergence of novel candidates up for clinical development.

Biotechnology Key Market Trends

  • Synthetic Biology: Biotechnology companies can focus on the rapidly growing popularity of the synthetic biology approach to maximize their revenue generation scope in the long run. From pharmaceuticals to fuels, synthetic biology is an approach that has the potential to revolutionize the world through biotechnology.

Biotechnology Market SkyQuest Analysis

SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.  

As per SkyQuest analysis, high prevalence of chronic diseases, growing investments in medical R&D, and high demand for personalized medicine are slated to boost biotechnology market growth. However, ethical concerns, complexity in biomanufacturing, and regulatory compliance are estimated to be the top restraints for biotechnology companies. High investments in medical R&D and quick adoption of novel technologies are key prospects that help North America maintain a dominance stance. Demand for red biotechnology is slated to bring in the most revenue across the study period. Developing synthetic biology products via biotechnology will pay off big time for biotechnology companies in the long run. 

Report Metric Details
Market size value in 2022 USD 1.21 Trillion
Market size value in 2031 USD 3.90 Trillion
Growth Rate 13.9%
Base year 2023
Forecast period 2024-2031
Forecast Unit (Value) USD Trillion
Segments covered
  • Type
    • Blue Biotechnology, Green Biotechnology, Red Biotechnology, White Biotechnology, Others
  • Product
    • Instrument & Reagent (Clinical Diagnostics, Proteomics and genomics, Drug Discovery & Development, Cell Analysis, Others), Software & Service
  • Technology
    • Nanobiotechnology, PCR Technology, Bioinformatics, Tissue Engineering, DNA sequencing, Fermentation Technology, Others
  • Application
    • Health, Agriculture, Food and Beverages, Industrial Processing, Others
Regions covered North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA)
Companies covered
  • AstraZeneca (UK) 
  • Gilead Sciences, Inc. (US) 
  • Biogen Inc. (US) 
  • Merck (Germany) 
  • Illumina, Inc. (US) 
  • Novo Nordisk A/S (Denmark) 
  • Thermo Fisher Scientific Inc. (US) 
  • Agilent Technologies, Inc. (US) 
  • Lonza Group AG (Switzerland) 
  • Pfizer Inc. (US) 
  • Bristol-Myers Squibb (US) 
  • Amgen Inc. (US) 
  • AbbVie Inc. (US) 
  • Regeneron Pharmaceuticals, Inc. (US) 
  • Vertex Pharmaceuticals Incorporated (US) 
  • Roche Holding AG (Switzerland) 
  • Johnson & Johnson Services, Inc. (US) 
  • Moderna, Inc. (US) 
  • Bio-Rad Laboratories, Inc. (US) 
  • Qiagen N.V. (Netherlands)
Customization scope

Free report customization with purchase. Customization includes:-

  • Segments by type, application, etc
  • Company profile
  • Market dynamics & outlook
  • Region

To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.

Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share

Table Of Content

Executive Summary

Market overview

  • Exhibit: Executive Summary – Chart on Market Overview
  • Exhibit: Executive Summary – Data Table on Market Overview
  • Exhibit: Executive Summary – Chart on Biotechnology Market Characteristics
  • Exhibit: Executive Summary – Chart on Market by Geography
  • Exhibit: Executive Summary – Chart on Market Segmentation
  • Exhibit: Executive Summary – Chart on Incremental Growth
  • Exhibit: Executive Summary – Data Table on Incremental Growth
  • Exhibit: Executive Summary – Chart on Vendor Market Positioning

Parent Market Analysis

Market overview

Market size

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • SWOT Analysis

KEY MARKET INSIGHTS

  • Technology Analysis
    • (Exhibit: Data Table: Name of technology and details)
  • Pricing Analysis
    • (Exhibit: Data Table: Name of technology and pricing details)
  • Supply Chain Analysis
    • (Exhibit: Detailed Supply Chain Presentation)
  • Value Chain Analysis
    • (Exhibit: Detailed Value Chain Presentation)
  • Ecosystem Of the Market
    • Exhibit: Parent Market Ecosystem Market Analysis
    • Exhibit: Market Characteristics of Parent Market
  • IP Analysis
    • (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
  • Trade Analysis
    • (Exhibit: Data Table: Import and Export data details)
  • Startup Analysis
    • (Exhibit: Data Table: Emerging startups details)
  • Raw Material Analysis
    • (Exhibit: Data Table: Mapping of key raw materials)
  • Innovation Matrix
    • (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
  • Pipeline product Analysis
    • (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
  • Macroeconomic Indicators

COVID IMPACT

  • Introduction
  • Impact On Economy—scenario Assessment
    • Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
  • Revised Market Size
    • Exhibit: Data Table on Biotechnology Market size and forecast 2021-2027 ($ million)
  • Impact Of COVID On Key Segments
    • Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
  • COVID Strategies By Company
    • Exhibit: Analysis on key strategies adopted by companies

MARKET DYNAMICS & OUTLOOK

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • Regulatory Landscape
    • Exhibit: Data Table on regulation from different region
  • SWOT Analysis
  • Porters Analysis
    • Competitive rivalry
      • Exhibit: Competitive rivalry Impact of key factors, 2021
    • Threat of substitute products
      • Exhibit: Threat of Substitute Products Impact of key factors, 2021
    • Bargaining power of buyers
      • Exhibit: buyers bargaining power Impact of key factors, 2021
    • Threat of new entrants
      • Exhibit: Threat of new entrants Impact of key factors, 2021
    • Bargaining power of suppliers
      • Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
  • Skyquest special insights on future disruptions
    • Political Impact
    • Economic impact
    • Social Impact
    • Technical Impact
    • Environmental Impact
    • Legal Impact

Market Size by Region

  • Chart on Market share by geography 2021-2027 (%)
  • Data Table on Market share by geography 2021-2027(%)
  • North America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • USA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Canada
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Europe
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Germany
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Spain
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • France
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • UK
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Europe
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Asia Pacific
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • China
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • India
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Japan
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Korea
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Asia Pacific
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Latin America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Brazil
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of South America
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Middle East & Africa (MEA)
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • GCC Countries
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Africa
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of MEA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)

KEY COMPANY PROFILES

  • Competitive Landscape
    • Total number of companies covered
      • Exhibit: companies covered in the report, 2021
    • Top companies market positioning
      • Exhibit: company positioning matrix, 2021
    • Top companies market Share
      • Exhibit: Pie chart analysis on company market share, 2021(%)

Methodology

For the Biotechnology Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:

1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.

2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Biotechnology Market.

3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.

4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.

Analyst Support

Customization Options

With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Biotechnology Market:

Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.

Regional Analysis: Further analysis of the Biotechnology Market for additional countries.

Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.

Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.

Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.

Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.

Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.

Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Biotechnology Market size was valued at USD 1.21 Trillion in 2022 and is poised to grow from USD 1.38 Trillion in 2023 to USD 3.90 Trillion by 2031, growing at a CAGR of 13.9% during the forecast period (2024-2031).

Biotechnology companies should solely focus on perfecting their R&D divisions first to maximize their business scope in the future. Collaborations, mergers, and capital raises are projected to be preferred strategies for incoming biotechnology companies looking to penetrate the market. Use of advanced technologies such as artificial intelligence and machine learning will also present new opportunities for biotechnology market players going forward. 'AstraZeneca (UK) ', 'Gilead Sciences, Inc. (US) ', 'Biogen Inc. (US) ', 'Merck (Germany) ', 'Illumina, Inc. (US) ', 'Novo Nordisk A/S (Denmark) ', 'Thermo Fisher Scientific Inc. (US) ', 'Agilent Technologies, Inc. (US) ', 'Lonza Group AG (Switzerland) ', 'Pfizer Inc. (US) ', 'Bristol-Myers Squibb (US) ', 'Amgen Inc. (US) ', 'AbbVie Inc. (US) ', 'Regeneron Pharmaceuticals, Inc. (US) ', 'Vertex Pharmaceuticals Incorporated (US) ', 'Roche Holding AG (Switzerland) ', 'Johnson & Johnson Services, Inc. (US) ', 'Moderna, Inc. (US) ', 'Bio-Rad Laboratories, Inc. (US) ', 'Qiagen N.V. (Netherlands)'

Incidence of chronic diseases such as cancer and diabetes has increased on a global level. Subsequently the demand for treatment of these diseases is also increasing at a rapid pace and fueling the global biotechnology market growth all over the world.  

Synthetic Biology: Biotechnology companies can focus on the rapidly growing popularity of the synthetic biology approach to maximize their revenue generation scope in the long run. From pharmaceuticals to fuels, synthetic biology is an approach that has the potential to revolutionize the world through biotechnology.

Robust investments in medical R&D are contributing to the high market share of North America. Presence of a developed healthcare infrastructure, quick adoption of novel technologies, and presence of key biotechnology companies are also helping this region’s dominance. The United States is slated to be the most opportune market for biotechnology companies in this region followed by Canada. Rapidly aging population and rising prevalence of cancer and diabetes are also expected to help boost biotechnology demand outlook in this region.  

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Report ID: SQMIG35H2249

$5,300
BUY NOW GET FREE SAMPLE